Literature DB >> 19245429

Colocalization of the VEGF-R2 and the common IL-3/GM-CSF receptor beta chain to lipid rafts leads to enhanced p38 activation.

Ernestina Saulle1, Roberta Riccioni, Simona Coppola, Isabella Parolini, Daniela Diverio, Viviana Riti, Gualtiero Mariani, Stefan Laufer, Massimo Sargiacomo, Ugo Testa.   

Abstract

Previous studies suggested an important role for vascular endothelial growth factor (VEGF) and its receptors in postnatal haemopoiesis. However, it is unclear how VEGF receptor (VEGFR) signalling could interact with that issued from the activation of haematopoietic growth factor receptors. To elucidate this point we explored VEGF-R2 and granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR) membrane localization and cell signalling in TF1-KDR cells (TF1 leukaemic cells that overexpress VEGF-R2/KDR). Activation of either GM-CSFR or VEGF-R2 was shown to determine the migration of both receptor elements (VEGF-R2 and the common beta-chain of the GM-CSFR) to lipid rafts. The study of receptor phosphorylation showed that GM-CSF induced the phosphorylation of its own receptor and the transphosphorylation of VEGF-R2; on the other hand, VEGF triggered the phosphorylation of its receptor and transphosphorylated the beta-chain of the GM-CSFR. Co-stimulation of TF1-KDR cells with both GM-CSF and VEGF-A resulted in massive migration of both the common GM-CSFR beta-chain and VEGF-R2 to lipid rafts and sustained p38 mitogen-activated protein kinase activation. Disruption of lipid rafts inhibited the capacity of both GM-CSF and VEGF-A to activate p38. Experiments with specific p38 inhibitors showed that p38 activation was required to sustain the VEGF- and GM-CSF-dependent proliferation of TF1-KDR and the survival of primary acute myeloid leukaemia blasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19245429     DOI: 10.1111/j.1365-2141.2009.07627.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  9 in total

Review 1.  Concise review: engineering the fusion of cytokines for the modulation of immune cellular responses in cancer and autoimmune disorders.

Authors:  Spencer Ng; Jacques Galipeau
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

Review 2.  Role of the β Common (βc) Family of Cytokines in Health and Disease.

Authors:  Timothy R Hercus; Winnie L T Kan; Sophie E Broughton; Denis Tvorogov; Hayley S Ramshaw; Jarrod J Sandow; Tracy L Nero; Urmi Dhagat; Emma J Thompson; Karen S Cheung Tung Shing; Duncan R McKenzie; Nicholas J Wilson; Catherine M Owczarek; Gino Vairo; Andrew D Nash; Vinay Tergaonkar; Timothy Hughes; Paul G Ekert; Michael S Samuel; Claudine S Bonder; Michele A Grimbaldeston; Michael W Parker; Angel F Lopez
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-06-01       Impact factor: 10.005

3.  Maltose-binding protein isolated from Escherichia coli induces Toll-like receptor 2-mediated viability in U937 cells.

Authors:  Zhao Xiaoxia; Ni Weihua; Zhang Qingyong; Wang Fengli; Li Yingying; Sun Xiaxia; Liu Zhonghui; Tai Guixiang
Journal:  Clin Transl Oncol       Date:  2011-07       Impact factor: 3.405

Review 4.  The receptor that tames the innate immune response.

Authors:  Michael Brines; Anthony Cerami
Journal:  Mol Med       Date:  2012-05-09       Impact factor: 6.354

Review 5.  Microdomains, Inflammation, and Atherosclerosis.

Authors:  Mary G Sorci-Thomas; Michael J Thomas
Journal:  Circ Res       Date:  2016-02-19       Impact factor: 17.367

6.  A fusion cytokine coupling GMCSF to IL9 induces heterologous receptor clustering and STAT1 hyperactivation through JAK2 promiscuity.

Authors:  Pingxin Li; Shala Yuan; Jacques Galipeau
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

7.  Role of plasma membrane caveolae/lipid rafts in VEGF-induced redox signaling in human leukemia cells.

Authors:  Cristiana Caliceti; Laura Zambonin; Benedetta Rizzo; Diana Fiorentini; Francesco Vieceli Dalla Sega; Silvana Hrelia; Cecilia Prata
Journal:  Biomed Res Int       Date:  2014-03-11       Impact factor: 3.411

8.  Lipid-Free Apolipoprotein A-I Reduces Progression of Atherosclerosis by Mobilizing Microdomain Cholesterol and Attenuating the Number of CD131 Expressing Cells: Monitoring Cholesterol Homeostasis Using the Cellular Ester to Total Cholesterol Ratio.

Authors:  Sushma Kaul; Hao Xu; Manal Zabalawi; Elisa Maruko; Brian E Fulp; Theresa Bluemn; Kristina L Brzoza-Lewis; Mark Gerelus; Ranjuna Weerasekera; Rachel Kallinger; Roland James; Yi Sherry Zhang; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Am Heart Assoc       Date:  2016-11-07       Impact factor: 5.501

Review 9.  Erythropoietin Receptor/β Common Receptor: A Shining Light on Acute Kidney Injury Induced by Ischemia-Reperfusion.

Authors:  Yuanyuan Wu; Bin Yang
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.